Inpatient and Outpatient Orderable
OnkoSight Advanced Chronic Lymphoid Neoplasm
Build info
Synonyms
|
- ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA
- "ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA NGS
- OSACLN
- ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOPLASMA N"
- LAB12276
|
Short Name
|
OnkoSight Advanced Chronic Lymphoid Neoplasm
|
Procedure Master Number
|
LAB12276
|
Procedure ID
|
137023
|
Clinical Info
|
Includes 41 Genes,
ATM BCL2 BCL6 BIRC3 BRAF BTK CARD11 CD79B CDKN2A CXCR4 DNMT3A EZH2 IDH1 IDH2
JAK1 JAK3 KMT2D MAP2K1 MYC MYD88 NOTCH1 NOTCH2 NRAS PLCG2 RHOA SETD2 SF3B1
STAT3 STAT5B TET2 TNFRSF14 TP53 CREBBP EP300 MEF2B PTPRD KRAS IKZF1 IRF4 PIK3CA
PIK3CG
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
Bone Marrow Aspirate
|
Specimen Types
|
Aspirate
Blood
Bone Marrow
|
Container
|
Lavender Top Tube
|
Collection Instructions
|
Container/Tube: Dark Green Top Tube
Specimen: 4 mL Bone marrow or Peripheral Blood
Transport Temperature: Room Temperature
Specimen Comment: Extracted DNA is acceptable, providing that the isolation of nucleic acid occurs
in a CLIA-certified laboratory or a laboratory meeting equivalent requirements as determined by CM
and/or the CAP.
|
Transport Instructions
|
Room Temperature
|
Specimen Stability
|
|
Methodology
|
Genotyping by Next Generation Sequencing
|
Days Performed
|
TAT: 10 Days
|
Performing Laboratory
|
BioReference Laboratory
Test Code: TH55
|
CPT
|
81450
|
PDM
|
235442
|
Only Orderable at Locations:
|
Orderable Everywhere
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP |
ONKOACHLYM |
ONKOSIGHT ADVANCED CHRONIC LYMPHOID NEOP |
OnkoSight Advanced Chronic Lymphoid Neop |
| THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
THERPROGASS |
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
Therapeutic And Prognostic Associations |
| INTERPRETATION SUMMARY |
INTERP |
INTERPRETATION SUMMARY |
Interpretation Summary |
| DETAILED GENETIC INTERPRETATION 1 |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 1 |
Detailed Genetic Interpretation 1 |
| DETAILED GENETIC INTERPRETATION 2 : |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 2 |
Detailed Genetic Interpretation 2 : |
| CLINICAL TRIALS 1 : |
CLINTRIAL |
CLINICAL TRIALS 1 |
Clinical Trials 1 : |
| CLINICAL TRIALS 2 : |
CLINTRIAL |
CLINICAL TRIALS 2 |
Clinical Trials 2 : |
| TECHNICAL SUMMARY : |
TECHSUM |
TECHNICAL SUMMARY |
Technical Summary : |
| METHODS |
METHODS |
METHODS |
Methods |
| REFERENCES 1 |
REF1 |
REFERENCES 1 |
References 1 |
| REFERENCES 2 |
REF2 |
REFERENCES 2 |
References 2 |
| REPORT FOOTER |
RPTFOOTER |
REPORT FOOTER |
Report Footer |
| ADDENDUM : |
ADDENDUM |
ADDENDUM |
|
|
